Unity Biotechnology Inc (UBX) — Financial Flexibility Index
Unity Biotechnology Inc (UBX) has a Financial Flexibility Index of -0.21x as of March 2025. Free cash flow of $-6.36 Million (operating CF $-6.36 Million minus capex $0.00) represents 0% of total liabilities ($30.55 Million). Check Unity Biotechnology Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Unity Biotechnology Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Unity Biotechnology Inc across 9 annual periods. See UBX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Unity Biotechnology Inc (2016–2024)
Year-by-year free cash flow to debt coverage for Unity Biotechnology Inc. For the full company profile including market capitalisation, see UBX stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.67x | $-20.86 Million | $-20.86 Million | $31.17 Million | ▲ +35.4% |
| 2023 | -1.04x | $-38.64 Million | $-38.65 Million | $37.29 Million | ▼ -17.0% |
| 2022 | -0.89x | $-50.93 Million | $-51.03 Million | $57.50 Million | ▼ -28.6% |
| 2021 | -0.69x | $-44.87 Million | $-45.06 Million | $65.14 Million | ▲ +34.9% |
| 2020 | -1.06x | $-77.69 Million | $-78.33 Million | $73.44 Million | ▲ +54.4% |
| 2019 | -2.32x | $-70.83 Million | $-72.42 Million | $30.51 Million | ▲ +13.3% |
| 2018 | -2.68x | $-55.36 Million | $-56.62 Million | $20.68 Million | ▲ +18.4% |
| 2017 | -3.28x | $-36.67 Million | $-38.36 Million | $11.18 Million | ▼ -3101.8% |
| 2016 | -0.10x | $-14.15 Million | $-16.40 Million | $138.18 Million | — |